Wei Dong Jiang
Fondatore presso SHANGHAI HENLIUS BIOTECH, INC.
Patrimonio netto: 2 M $ in data 30/04/2024
Posizioni attive di Wei Dong Jiang
Società | Posizione | Inizio | Fine |
---|---|---|---|
SHANGHAI HENLIUS BIOTECH, INC. | Direttore Tecnico/Scientifico/R&S | 01/12/2009 | - |
Fondatore | 01/12/2009 | - |
Storia della carriera di Wei Dong Jiang
Precedenti posizioni note di Wei Dong Jiang
Società | Posizione | Inizio | Fine |
---|---|---|---|
Henlius Biopharmaceuticals, Inc.
Henlius Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Henlius Biopharmaceuticals, Inc. focuses on development and commercialization of mAb-based therapeutics biosimilars and biobetter for malignant tumors and auto-immune diseases. The company was founded by Scott Liu and Paul Liu in 2009 and is headquartered in Fremont, CA. | Direttore Tecnico/Scientifico/R&S | 01/01/2009 | - |
Fondatore | 01/01/2009 | - |
Formazione di Wei Dong Jiang
Zhejiang University | Undergraduate Degree |
University of Giessen | Doctorate Degree |
Statistiche
Distribuzione geografica
Cina | 3 |
Stati Uniti | 2 |
Germania | 2 |
Posizioni
Chief Tech/Sci/R&D Officer | 2 |
Founder | 2 |
Undergraduate Degree | 1 |
Settori
Health Technology | 3 |
Consumer Services | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 1 |
---|---|
SHANGHAI HENLIUS BIOTECH, INC. | Health Technology |
Aziende private | 1 |
---|---|
Henlius Biopharmaceuticals, Inc.
Henlius Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Henlius Biopharmaceuticals, Inc. focuses on development and commercialization of mAb-based therapeutics biosimilars and biobetter for malignant tumors and auto-immune diseases. The company was founded by Scott Liu and Paul Liu in 2009 and is headquartered in Fremont, CA. | Health Technology |
- Borsa valori
- Insiders
- Wei Dong Jiang
- Esperienza